Society & Culture
Episode 19: The middle Road interviews Dr. Chandrakant Lahariya Thought Leader -- Public Policy & Health Systems Expert
In this episode, I will have an in-depth conversation with Dr. Chandrakant Lahariya, one of the foremost healthcare experts and thought leaders in Asia. Our conversation covers various aspects of the pandemic and a must for anyone interested in understanding the efforts of global actors within the healthcare ecosystem in fighting the COVID-19 pandemic. Learn more about mRNA vaccines, difference between Mucormycosis and Black Fungus, Remdesivir divergent results, overview of the randomized double-blind controlled trial, steroids as a COVID-19 response, Delta variant and much more.
Dr. Chandrakant is a leading epidemiologist, public policy and health systems expert based in India. He is also the co-author of the book Till We Win, an extremely insightful, informative, and fluid book on COVID-19 and India’s fight against the COVID-19 pandemic. Dr. Gagandeep Kang and Dr. Randeep Guleria are the other co-authors of the book. Dr. Chandrakant Lahariya is the youngest fellow ever to be elected to the Indian Public Health Association (IPHA), that works with leading healthcare experts to design healthcare policies and programs at the state and national level in India. He is presently focusing on universal and primary healthcare in India.
Viruses stand at 1031 compared to the human population at 8 billion i.e. 8*109, a telling figure of how dangerous our ecosystem can become.
Hello, Dr. Chandrakant delighted to have you for a thought-provoking conversation.
First, I highly recommend people to read Till We Win for getting an excellent perspective about viruses, drugs and therapies, and the evolving COVID-19 response significantly in India during the pandemic. Let’s go top-down and understand a bit about viruses. Edward Jenner developed the first vaccine using the cowpox virus against smallpox. From Black Plague to the Spanish Flu to the COVID-19, humans have been ravaged by pandemics for a long time. Till We Win shares a vivid history about viruses so we being our discussion with the coronavirus. Till We Win begins with stunning reality. How viruses dwarf the count of humans on our planet.
Read the full question list.
Episode 20: The middle Road interviews Naghma Mulla CEO EdelGive Foundation
Episode 18: The middle Road chats with Anu Prasad Founder & CEO of India Leaders for Social Sector (ILSS)
Episode 17: The middle Road chats with Dr Robert Karanja, Co-founder of Villgro Africa
Episode 16: The middle Road chats with Brooke Burton, Founder of The People's Club
Episode 15: The middle Road interviews Erica Mills Barnhart, Founder of Claxon Marketing and Claxon University
Episode 14: The middle Road interviews Larry Johnson, Founder The Eight Principles
Episode 13 : The middle Road interviews Ronald Abraham, Founding Partner and India Director, IDinsight
Episode 12: The middle Road interviews Gireendra Kasmalkar, Founder Ideas 2 Impacts
Episode 11: Nishant Malhotra Founder of Middle Road OPC Pvt Ltd (www.themiddleroad.org) on Sustainable Finance
Webinar 1 Circular Economy & Evolving Sustainable Finance
Episode 10: The middle Road interviews Ramanan Ramanathan, Mission Director, Atal Innovation Mission
Episode 9: The middle Road interviews Dr Taslimarif
Episode 8: The middle Road has a candid chat with Mr Manoj Kumar
Episode 7: The middle Road Interviews Ms Shilpa Pophale
Episode 6:The middle Road interviews Tom Adlam
Episode 5: The middle Road with Dr. V Premnath, Co Founder & Director, Venture Center
Episode 4: The middle Road founder Nishant Malhotra Speaks with Prof Thomas Finholt, Dean School of Information, University of Michigan, Ann Arbor
Episode 3: The middle Road speaks with Jagdish Kini Ex MD, Gillette India & Ex ED and CEO Bharti Airtel Ltd.
Episode 1: The middle Road with Ruchi Mathur CEO Pune City Connect
#ElderWisdom | Stories from the Green Bench
Stuff You Should Know
Supernatural with Ashley Flowers
Copyright © 2006-2021 Podbean.com